Weitai Medical-B (02235): The China Securities Regulatory Commission issued a notice on the company's implementation of full circulation of H shares

Zhitongcaijing · 2d ago

According to the Zhitong Finance App, Weitai Medical-B (02235) issued an announcement. The company has recently received a filing notice from the China Securities Regulatory Commission regarding the full circulation of the company's 250 million domestic shares. According to the filing notice, the company has completed the filing with the China Securities Regulatory Commission to convert the above domestic shares into the company's H shares and list them on the Stock Exchange.